RNA therapeutics leverage the ability of RNA to encode functional proteins or regulate biological pathways directly in vivo. Crystal NAX supports the development of diverse RNA drug modalities, including mRNA and self-amplifying RNA, with integrated design, delivery, and characterization capabilities. Our platform enables rapid optimization of RNA constructs and LNP formulations to support next-generation therapeutic programs.
RNA plays a central role in modern gene editing technologies, serving as both a guide and a transient effector. Crystal NAX supports gene editing applications through high-fidelity sgRNA synthesis, advanced delivery system development, and comprehensive analytical characterization. Our technologies enable precise control and evaluation of genome editing tools in research and preclinical settings.
In vivo cell therapy uses RNA and delivery systems to directly reprogram or engineer cells within the body. Crystal NAX enables this emerging application through intelligent RNA design, targeted LNP delivery strategies, and robust functional characterization. Our platform supports the development of RNA systems that enable controlled, transient, and tissue-specific cellular modulation.
RNA-based immunization has become a powerful tool for vaccine development, antigen discovery, and immune response evaluation. Crystal NAX supports animal immunization studies with high-quality RNA synthesis, ready-to-use delivery systems, and in-depth analytical support. Our integrated approach enables efficient evaluation of antigen expression, immune activation, and formulation performance in preclinical models.
